Proteo, Inc. (OTCMKTS:PTEO – Get Free Report) shares crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.09 and traded as low as $0.09. Proteo shares last traded at $0.09, with a volume of 0 shares traded.
Proteo Stock Performance
The firm’s 50 day simple moving average is $0.09 and its 200-day simple moving average is $0.09.
Proteo Company Profile
Proteo, Inc, a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company focuses on the development of pharmaceuticals based on Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands for use in the treatment of post-surgery damage to tissue; complications resulting from organ transplantation; pulmonary hypertension; and injuries caused by accidents, cardiac infarction, and other diseases.
Recommended Stories
- Five stocks we like better than Proteo
- Canada Bond Market Holiday: How to Invest and Trade
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- Are Penny Stocks a Good Fit for Your Portfolio?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- About the Markup Calculator
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Proteo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteo and related companies with MarketBeat.com's FREE daily email newsletter.
